Company Announcements

CARLSBAD, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced its participation in the upcoming Latin America Pain Society (LAPS) Annual Congress September 5-7, 2024, in Mexico City.

The event will provide Aurora Spine with a platform to present its latest advancements in minimally invasive spinal devices and pain management solutions. These technologies are designed to optimize patient care, reduce recovery times, and improve quality of life. Aurora Spine’s cutting-edge developments focus on addressing the unique challenges in spine and pain treatment, positioning the company as a pioneer in the medical device industry.

This world-class LAPS congress presents outstanding, nationally and internationally renowned experts in pain management to share their knowledge and present the opportunity to interact with peers.

Matt Goldstone, Chief Commercial Officer of Aurora Spine, stated, “We are very excited to be participating in this year’s LAPS Conference. This world-class LAPS Congress showcases cutting-edge advances and state-of-the-art technologies to present the latest research, techniques and products for better patient care.”

About Aurora Spine

Aurora Spine is focused on bringing new solutions to the spinal implant and pain markets through a series of innovative, minimally invasive, regenerative spinal implant technologies. Aurora Spine is an emerging growth company focused on bringing new solutions to the spinal implant and pain care markets through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com or www.aurorapaincare.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

Contact:

Aurora Spine Corporation

Trent Northcutt
President and Chief Executive Officer
(760) 424-2004

Chad Clouse
Chief Financial Officer
(760) 424-2004
www.aurora-spine.com